Table 1.
Classification of cholangiopathies.
| Genetic |
|---|
| Alagille's syndrome |
| Caroli's syndrome |
| Cystic fibrosis |
| MDR3 deficiency |
| Polycystic liver disease (ADPLD, ADPKD, ARPKD) |
| Immune-mediated |
| Acute allograft rejection |
| Chronic allograft rejection |
| Graft versus host disease |
| Primary biliary cholangitis |
| Idiopathic |
| Biliary atresia |
| Idiopathic childhood/adulthood ductopenia |
| IgG4 cholangiopathy |
| Primary sclerosing cholangitis |
| Sarcoidosis |
| Infectious |
| AIDS cholangiopathy (e.g., viral cholangitis) |
| Bacterial cholangitis (e.g., Escherichia coli, Klebsiella, Enterococcus, Enterobacter, Pseudomonas, anaerobes) |
| Parasitic cholangitis (e.g., Ascaris lumbricoides, Opisthorchis viverrini, Clonorchis sinensis, Fasciola hepatica) |
| Malignant |
| Cholangiocarcinoma |
| Other |
| Drug-induced (e.g., Floxuridine-induced cholangiopathy, ketamine cholangiopathy) |
| Vascular/ischemic (e.g., post-liver transplant hepatic artery stenosis, systemic vasculitis) |
Abbreviations: ADPKD, autosomal dominant polycystic kidney disease; ADPLD, autosomal dominant polycystic liver disease; AIDS, acquired immunodeficiency syndrome; ARPKD, autosomal recessive polycystic kidney disease; IgG4, immunoglobulin G subclass 4; MDR3, multidrug resistance 3.